Ongoing research projects
- ”Behavioral, affective and cognitive consequences of bariatric surgery”
- ”Effects of the appetite-inducing hormone ghrelin on decision making in healthy volunteers”
Ghrelin, a hormone produced in the stomach, is the endogenous ligand for the growth hormone secretagogue receptor (GHSR), and promotes appetite through hypothalamic actions. GHS-R is also expressed in brain areas involved in motivation and decision-making, such as the mesolimbic dopamine (DA) pathway. Reduction of ghrelin levels is thought to be an important mechanism contributing to the weight loss following bariatric surgery. Findings also have shown that ghrelin influences drug- and food reward as well as novelty seeking. Finally, ghrelin also plays a role in integrating central circuitry involved in anxiety and responses to stress.
Decision making processes that involve reward and risk assessment subserve the solution of the tradeoff between exploiting available resources vs exploring the environment for novel resources. We hypothesize that these processes are modulated by signals that communicate the availability of food.
